payers Archives -

As specialty therapies move toward long-term maintenance use and as treatment times grow longer, government and commercial payers

Improving access and reimbursement for specialty therapies

https://pharmaphorum.com/views-analysis-market-access/improving-access-and-reimbursement-for-specialty-therapies/

The disconnect between payers and pharma companies is just one symptom of pharma’s outdated business model, according to

Time to fix pharma’s outdated business model

https://pharmaphorum.com/digital/time-to-fix-pharmas-outdated-business-model/

Rivals Novo Nordisk, Sanofi, and AstraZeneca also offering digital health services.

Lilly collaborating with digital firm in ‘real world’ diabetes studies

https://pharmaphorum.com/views-and-analysis/lilly-collaborating-diabetes-firm-real-world-studies/

Typical patient support programs fail to improve adherence – and it’s costing the pharma industry billions. Here’s how

How to fix your adherence problem

https://pharmaphorum.com/partner-content-patients/fix-adherence-problem/

Health systems should fund more treatments for chronic diseases, says EFPIA

OECD calls for ‘rebalancing of power’ in drug price negotiations

https://pharmaphorum.com/news/oecd-calls-for-rebalancing-of-power-in-drug-price-negotiations/

payers